Google Advertisement
Beijing, Oktober 18, 2026 – China’s research and development (R&D) expenditure soared to US$584.5 billion in 2025, an 8.2 percent increase from the previous year, underscoring Beijing’s determination to anchor its economic future in innovation.
The figure, equivalent to 3.93 trillion yuan, marks the first time China’s R&D intensity has surpassed the OECD average, reaching 2.8 percent of GDP compared with 2.72 percent among member nations.
Enterprises remain the backbone of this surge, contributing nearly 77.4 percent of total spending over 3 trillion yuan and driving more than 73 percent of the overall increase.
This corporate dominance reflects China’s reliance on both private and state-owned firms to spearhead advances in semiconductors, artificial intelligence, biotechnology, and renewable energy.
Google Advertisement
The government’s role, while significant, is increasingly focused on setting strategic priorities and funding basic research.
The breakdown of spending reveals a nuanced picture.
Basic research rose 13.3 percent to 283.46 billion yuan, signaling Beijing’s intent to strengthen the foundations of scientific inquiry.
Applied research grew modestly at 3.2 percent to 444.16 billion yuan, while experimental development closely tied to commercialization expanded 8.4 percent to 3.2 trillion yuan.
Analysts note that while the emphasis on basic science is encouraging, slower growth in applied research could pose challenges in bridging discoveries with market-ready technologies.
Globally, China now stands as the second-largest R&D investor, trailing only the United States.
Its rapid ascent highlights a shifting balance in innovation power centers, with Asia increasingly shaping the trajectory of technological competition.
Surpassing the OECD average is both symbolic and strategic, reinforcing China’s ambition to close the gap with advanced economies and assert leadership in critical sectors.
Yet risks remain. Geopolitical tensions, particularly U.S. led export controls on advanced technologies, threaten to constrain access to vital inputs.
Domestically, questions persist about whether the quality of research can match the scale of investment, and whether enterprises can sustain innovation amid economic headwinds.
The uneven pace between basic and applied research further raises concerns about bottlenecks in commercialization.
Still, the trajectory is clear China is betting heavily on innovation as the engine of future growth.
With enterprises at the forefront and government policy steering the course, the country’s R&D surge signals not just a statistical milestone but a strategic pivot toward long-term competitiveness in the global economy.
